RxDoctor Payments DataLook up a doctor →

Jaideep Behari, MD

Gastroenterology · Pittsburgh, PANPI 1528087939

Payments from drug & device makers

$2,728,216in general payments, 2019–2025

Across 283 payments — averaging $9640.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intercept Pharmaceuticals, Inc.$932K
  • Pfizer$663K
  • Gilead$403K
  • AbbVie$221K
  • Madrigal Pharmaceuticals$200K
  • Intercept Pharma Europe Ltd.$167K
  • plus $141K from 5 others
$780in research payments, 2019–2025

Across 1 payment — averaging $780.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$780

General payments by program year

22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,728,216 in reported general payments places this provider in the 95th percentile of 935 gastroenterology providers in Pennsylvania.

See all gastroenterology providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$19,083
Medicare patients
120
Services billed
185

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other gastroenterology in Pittsburgh

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →